291 related articles for article (PubMed ID: 8196827)
1. [Clinical study on the recurrence of meningiomas: correlating factors for the recurrence and therapeutic prognosis of meningiomas].
Miyagami M; Miyagi A; Kido G; Tsubokawa T
No Shinkei Geka; 1994 May; 22(5):421-8. PubMed ID: 8196827
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
[TBL] [Abstract][Full Text] [Related]
3. Convexity meningiomas: study of recurrence factors with special emphasis on the cleavage plane in a series of 100 consecutive patients.
Alvernia JE; Dang ND; Sindou MP
J Neurosurg; 2011 Sep; 115(3):491-8. PubMed ID: 21663413
[TBL] [Abstract][Full Text] [Related]
4. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
Roser F; Samii M; Ostertag H; Bellinzona M
Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
[TBL] [Abstract][Full Text] [Related]
5. Assessment of proliferative potential of meningiomas using PCNA LI and AgNOR counts.
Sudha K; Karak AK; Sharma MC; Mathur M; Sarkar C
Indian J Pathol Microbiol; 1998 Jul; 41(3):323-30. PubMed ID: 9805855
[TBL] [Abstract][Full Text] [Related]
6. Long-term surgical outcomes of spinal meningiomas.
Nakamura M; Tsuji O; Fujiyoshi K; Hosogane N; Watanabe K; Tsuji T; Ishii K; Toyama Y; Chiba K; Matsumoto M
Spine (Phila Pa 1976); 2012 May; 37(10):E617-23. PubMed ID: 22146282
[TBL] [Abstract][Full Text] [Related]
7. [Importance of meningioma. Clinico-epidemiologic and histologic studies].
Guski M; Martin H
Zentralbl Neurochir; 1984; 45(3):219-32. PubMed ID: 6506933
[TBL] [Abstract][Full Text] [Related]
8. [Clinical analysis of malignant meningiomas].
Kojima T; Waga S; Itoh H; Matsubara T; Kuga Y
No Shinkei Geka; 1990 Oct; 18(10):939-46. PubMed ID: 2234295
[TBL] [Abstract][Full Text] [Related]
9. Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up.
Lanzafame S; Torrisi A; Barbagallo G; Emmanuele C; Alberio N; Albanese V
Pathol Res Pract; 2000; 196(7):483-8. PubMed ID: 10926326
[TBL] [Abstract][Full Text] [Related]
10. Spheno-orbital meningiomas: surgical approaches and outcome according to the intraorbital tumor extent.
Mariniello G; Maiuri F; Strianese D; Donzelli R; Iuliano A; Tranfa F; de Divitiis E; Bonavolontà G
Zentralbl Neurochir; 2008 Nov; 69(4):175-81. PubMed ID: 18666054
[TBL] [Abstract][Full Text] [Related]
11. Surgery for convexity meningiomas.
Morokoff AP; Zauberman J; Black PM
Neurosurgery; 2008 Sep; 63(3):427-33; discussion 433-4. PubMed ID: 18812953
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of recurrences of meningiomas following neurosurgical resection].
Kajiwara K; Fudaba H; Tsuha M; Ueda H; Mitani T; Nishizaki T; Aoki H
No Shinkei Geka; 1989 Dec; 17(12):1125-31. PubMed ID: 2615895
[TBL] [Abstract][Full Text] [Related]
13. Childhood and adolescent meningiomas: a report of 38 cases and review of literature.
Menon G; Nair S; Sudhir J; Rao BR; Mathew A; Bahuleyan B
Acta Neurochir (Wien); 2009 Mar; 151(3):239-44; discussion 244. PubMed ID: 19238320
[TBL] [Abstract][Full Text] [Related]
14. Surgical management of jugular foramen meningiomas: a series of 13 cases and review of the literature.
Sanna M; Bacciu A; Falcioni M; Taibah A; Piazza P
Laryngoscope; 2007 Oct; 117(10):1710-9. PubMed ID: 17690614
[TBL] [Abstract][Full Text] [Related]
15. Parasagittal meningiomas: follow-up review.
Colli BO; Carlotti CG; Assirati JA; Dos Santos MB; Neder L; Dos Santos AC
Surg Neurol; 2006; 66 Suppl 3():S20-7; discussion S27-8. PubMed ID: 17081848
[TBL] [Abstract][Full Text] [Related]
16. [A case of recurrent convexity meningioma with malignant transformation 26 years after total tumor removal].
Ohta M; Takeshita I
No Shinkei Geka; 2001 Jan; 29(1):81-5. PubMed ID: 11218772
[TBL] [Abstract][Full Text] [Related]
17. Does protein expression predict recurrence of benign World Health Organization grade I meningioma?
Kärjä V; Sandell PJ; Kauppinen T; Alafuzoff I
Hum Pathol; 2010 Feb; 41(2):199-207. PubMed ID: 19801161
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
[TBL] [Abstract][Full Text] [Related]
19. Treatment of tuberculum sellae meningiomas:a long-term follow-up study.
Ohta K; Yasuo K; Morikawa M; Nagashima T; Tamaki N
J Clin Neurosci; 2001 May; 8 Suppl 1():26-31. PubMed ID: 11386822
[TBL] [Abstract][Full Text] [Related]
20. Relationship between malignant subtypes of meningioma and clinical outcome.
Ko KW; Nam DH; Kong DS; Lee JI; Park K; Kim JH
J Clin Neurosci; 2007 Aug; 14(8):747-53. PubMed ID: 17499508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
